- Home
- CHRW vs NBIX Comparison
CHRW vs NBIX Comparison
Compare CHRW & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHRW | NBIX |
|---|---|---|
| Founded | 1905 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.0B | 13.9B |
| IPO Year | 1997 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CHRW | NBIX |
|---|---|---|
| Price | $169.20 | $127.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 22 |
| Target Price | $174.53 | ★ $175.27 |
| AVG Volume (30 Days) | ★ 1.5M | 834.9K |
| Earning Date | 04-29-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.49% | N/A |
| EPS Growth | 25.13 | ★ 41.95 |
| EPS | ★ 4.83 | 4.67 |
| Revenue | ★ $14,869,380,000.00 | $161,626,000.00 |
| Revenue This Year | $4.33 | $22.85 |
| Revenue Next Year | $6.54 | $9.99 |
| P/E Ratio | $34.87 | ★ $27.40 |
| Revenue Growth | N/A | ★ 977.51 |
| 52 Week Low | $84.68 | $84.23 |
| 52 Week High | $203.34 | $160.18 |
Technical Indicators
Market Signals| Indicator | CHRW | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 41.68 | 42.25 |
| Support Level | $148.27 | $122.82 |
| Resistance Level | $194.54 | $136.74 |
| Average True Range (ATR) | 5.72 | 2.88 |
| MACD | -1.01 | -0.02 |
| Stochastic Oscillator | 13.08 | 32.83 |
Price Performance
Historical ComparisonAbout CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 60% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (30%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of transportation management services and a legacy produce-sourcing operation.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.